All Cosmos Bio-Tech Holding Corporation (TPE:4148)
Taiwan · Delayed Price · Currency is TWD 36.50
0.00 (0.00%)
Feb 11, 2026, 1:30 PM CST
TPE:4148 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 137.92 | 128.59 | 139.36 | 368.2 | 198.13 | 82.2 |
Depreciation & Amortization | 62.81 | 53.24 | 48.85 | 48.49 | 48.08 | 49.24 |
Other Amortization | 0.97 | 0.74 | 0.29 | 0.52 | 0.51 | 0.91 |
Loss (Gain) From Sale of Assets | 2.21 | -1.2 | 0.42 | 0.03 | 0.12 | -0.15 |
Asset Writedown & Restructuring Costs | 0.8 | 0.8 | - | - | - | - |
Loss (Gain) From Sale of Investments | -3.04 | -5.78 | 7.81 | 2.75 | -6.1 | -2.64 |
Loss (Gain) on Equity Investments | -3.39 | -2.81 | -5.35 | -1.93 | -1.69 | 1.3 |
Provision & Write-off of Bad Debts | 3.47 | 7.84 | -2 | -7.26 | -60.51 | -7.63 |
Other Operating Activities | 66.42 | 73.67 | -26.86 | 131.42 | 112.61 | 24.86 |
Change in Accounts Receivable | -214.6 | -145.73 | 248.99 | -234.89 | 140.07 | -221.68 |
Change in Inventory | -21.63 | -28.81 | 537.7 | -250.48 | -598.11 | 10.14 |
Change in Accounts Payable | 14.17 | -49.82 | 47.98 | -21.7 | 3.41 | -7.02 |
Change in Unearned Revenue | -1.62 | 1.53 | -4.97 | -1.35 | 7.09 | -1.38 |
Change in Other Net Operating Assets | 37.78 | 21.28 | -33.37 | 7.18 | 84.91 | -55.16 |
Operating Cash Flow | 83.81 | 54.19 | 959.24 | 43.84 | -67.64 | -126.88 |
Operating Cash Flow Growth | - | -94.35% | 2087.90% | - | - | - |
Capital Expenditures | -49.43 | -139.7 | -162.75 | -60.76 | -103.7 | -34.96 |
Sale of Property, Plant & Equipment | 0.31 | 1.51 | 0.33 | - | 0.01 | 0.27 |
Cash Acquisitions | - | - | 29.64 | - | - | - |
Sale (Purchase) of Intangibles | -0.7 | -2.55 | -0.67 | -0.1 | -0.14 | -0.23 |
Investment in Securities | -130.89 | -98.37 | -77.04 | 56.27 | -4.66 | 169.49 |
Other Investing Activities | 12.84 | 10.66 | 7.52 | -0.08 | 0.34 | -2.97 |
Investing Cash Flow | -317.53 | -228.46 | -202.98 | -4.67 | -108.17 | 131.61 |
Short-Term Debt Issued | - | 187.55 | - | 1,330 | 726.17 | 45.6 |
Long-Term Debt Issued | - | - | - | 558.31 | - | - |
Total Debt Issued | 500.37 | 187.55 | - | 1,888 | 726.17 | 45.6 |
Short-Term Debt Repaid | - | -24.83 | -386.48 | -1,279 | -458.21 | -8.87 |
Long-Term Debt Repaid | - | -484.68 | -15.73 | -10.38 | -5.66 | -17.47 |
Total Debt Repaid | -378.9 | -509.51 | -402.21 | -1,290 | -463.87 | -26.34 |
Net Debt Issued (Repaid) | 121.47 | -321.96 | -402.21 | 598.68 | 262.31 | 19.26 |
Common Dividends Paid | -32.02 | -64.03 | -160.09 | -96.05 | -64.03 | -64.03 |
Other Financing Activities | -25.6 | -42.5 | 12.42 | -12.24 | -2.18 | -1.33 |
Financing Cash Flow | 63.86 | -428.49 | -549.88 | 490.39 | 196.1 | -46.1 |
Foreign Exchange Rate Adjustments | -70.95 | 77.83 | -89.03 | 71.51 | -41.66 | -34.42 |
Net Cash Flow | -240.81 | -524.94 | 117.35 | 601.07 | -21.37 | -75.78 |
Free Cash Flow | 34.37 | -85.51 | 796.49 | -16.92 | -171.35 | -161.84 |
Free Cash Flow Margin | 1.22% | -3.48% | 28.18% | -0.46% | -7.80% | -9.85% |
Free Cash Flow Per Share | 0.51 | -1.26 | 10.72 | -0.24 | -2.54 | -2.40 |
Cash Interest Paid | 14.12 | 5.72 | 3.17 | 19.31 | 4.13 | 4.36 |
Cash Income Tax Paid | 85.28 | 66.95 | 130.55 | 166.64 | 42.25 | 45.52 |
Levered Free Cash Flow | 85.84 | -344.7 | 777.56 | -85.77 | -345.73 | -168.54 |
Unlevered Free Cash Flow | 94.55 | -340.89 | 780.05 | -74.01 | -342.9 | -165.76 |
Change in Working Capital | -184.37 | -200.89 | 796.71 | -498.38 | -358.79 | -274.97 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.